Product Images Enoxaparin Sodium

This appears to be a table of subgroup analysis related to a medical study that involves patients who suffered from an anterior infarct. The table shows the impact of different factors (such as sex, age, diabetes, prior MI, fibrinolytic agent, time to treatment, and PCl in 30 Days) on the relative risk reduction of the two treatments under comparison - UFH and Enoxaparin. The table also provides the number of patients in each subgroup, and the percentage reduction in risk associated with each treatment. The last row summarizes the overall results and shows which treatment is better, with Enoxaparin being favored.*

This is a graph showing the Hazard Distribution Function for Enoxaparin in comparison to UFH. The x-axis is the time to death or myocardial re-infarction in days and the y-axis shows the probability density of the event occurrence. The hazard function for Enoxaparin is higher than that of UFH, indicating a higher risk of the event occurring. The graph also shows a Log-Rank Test with a p-value of less than 0.0001, indicating statistical significance. Another Log-Rank Test with a p-value of 0.0111 is also visible. The table below the graph represents the time to death or myocardial re-infarction in days and the number of individuals at risk for each treatment (Enoxaparin and UFH) at that point in time.*

This is a medication label for Enoxaparin, which is a prescription drug indicated for the prevention and treatment of deep vein thrombosis. The NDC (National Drug Code) number is provided as NDC71288-432.80 and it can only be used with a valid prescription. The rest of the text appears to be unreadable or irrelevant.*

This text appears to be a label of Enoxaparin Sodium Injection, which is a prescription medicine used to prevent and treat blood clots. It contains 40mg of Enoxaparin Sodium in each 0.4mL dose. The label includes the National Drug Code (NDC) and indicates that it should only be used with a prescription.*

Enoxaparin Sodium Injection, USP is a single dose vial, intended for subcutaneous injection, containing 40mg of medication per 0.4 mL. The vial is equipped with an automatic safety device, making it a safe option for users. The product is manufactured by St. Nnprogen Prsnatve and should be used under the guidance of healthcare professionals.*

This is a description of a medication called Enoxaparin, with NDC code 71288-436-88. It is a Sodium Injection used for subcutaneous injection and comes in a concentration of 100mg per mL. The origin or meaning of "Poel Hore" and the characters "E," "£," and "I}" are not available.*

This appears to be a mixture of random characters, numbers, and product names, with some text indicating the use and dosage of Enoxaparin Sodium Injection for subcutaneous injection. It is not readable as a coherent description.*

Enoxaparin Sodium Injection, USP is a medication that comes in the form of an injection. The dosage of the medication is 12mg per 0.8 and the product is identified by the National Drug Code (NDC) number NDC71288-437-91.*

This is a product information sheet for Enoxaparin, a medication used for subcutaneous injection. The sheet lists the dosage as 20mg per 0.8 mL and indicates that it is an automatic safety device. The medication is also referred to as Enoxaparin Sodium Injection, USP. The rest of the text is not readable.*

This is a label of Enoxaparin Sodium Injection, USP medication showing the drug name, strength (150mg per mL), and route of administration (either intravenous or subcutaneous injection). The NDC number and prescription-only designation are also included.*